Cargando…

Multiple Autoimmune Skin Manifestations in a Patient with Crohn's Disease Treated with a Tumor Necrosis Factor-Alpha Blocker

Detalles Bibliográficos
Autores principales:	Zattra, Edoardo, D'Incà, Renata, Bertollo, Giuseppe, Tositti, Luca, Russo, Irene, Alaibac, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Dermatological Association; The Korean Society for Investigative Dermatology 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622898/ https://www.ncbi.nlm.nih.gov/pubmed/26512178 http://dx.doi.org/10.5021/ad.2015.27.5.612

Ejemplares similares

Measuring disease activity in Crohn’s disease: what is currently available to the clinician
por: D’Incà, Renata, et al.
Publicado: (2014)

Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions
por: Alaibac, Mauro
Publicado: (2018)

Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases
por: Marzano, Angelo V., et al.
Publicado: (2015)

In Vitro Evaluation of Sunscreens: An Update for the Clinicians
por: Pelizzo, Maria, et al.
Publicado: (2012)

Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario
por: Zingone, Fabiana, et al.
Publicado: (2020)

Biochip Technology for the Serological Diagnosis of Bullous Pemphigoid
por: Zarian, Haik, et al.
Publicado: (2012)

Efficacy of teduglutide in a patient with Crohn’s disease and short bowel syndrome on enteral nutrition: let’s start to think out of the box
por: Barberio, Brigida, et al.
Publicado: (2019)

Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease
por: Merigo, Flavia, et al.
Publicado: (2020)

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
por: Barberio, Brigida, et al.
Publicado: (2020)

Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
por: Michielan, Andrea, et al.
Publicado: (2015)

Biomarkers in IBD: What to Utilize for the Diagnosis?
por: D’Incà, Renata, et al.
Publicado: (2023)

Editorial: Cutaneous manifestations of systemic disease
por: Sernicola, Alvise, et al.
Publicado: (2023)

The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project
por: Leeb, Burkhard F., et al.
Publicado: (2009)

Effects of Tumor Necrosis Factor Alpha Blocker Adalimumab in Experimental Spinal Cord Injury
por: Börcek, Alp Özgün, et al.
Publicado: (2015)

Immune-Mediated Skin Diseases: Future Therapeutic Perspectives
por: Alaibac, Mauro
Publicado: (2023)

Crohn’s Disease Localization Displays Different Predisposing Genetic Variants
por: Palmieri, Orazio, et al.
Publicado: (2017)

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn’s Disease
por: Thurlapati, Aswani, et al.
Publicado: (2021)

Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls
por: Casula, Milena, et al.
Publicado: (2009)

Vitamins and Melanoma
por: Russo, Irene, et al.
Publicado: (2015)

Reflectance Confocal Microscopy in Evaluating Skin Cancer: A Clinicians's Perspective
por: Filoni, Angela, et al.
Publicado: (2019)

The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease
por: Alourfi, Mansour, et al.
Publicado: (2020)

Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease
por: Woo, Min Hyung, et al.
Publicado: (2019)

DNA-free genome editing in grapevine using CRISPR/Cas9 ribonucleoprotein complexes followed by protoplast regeneration
por: Najafi, Samaneh, et al.
Publicado: (2022)

Neoplastic and Autoimmune Comorbidities in Patients with Primary Cutaneous B-Cell Lymphoma
por: Mazzetto, Roberto, et al.
Publicado: (2023)

Nasal Skin Necrosis: A Very Rare Manifestation of Antiphospholipid Syndrome
por: Ourique, Carolina, et al.
Publicado: (2017)

Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
por: Sernicola, Alvise, et al.
Publicado: (2019)

Primary Cutaneous B-Cell Lymphomas in Patients With Impaired Immunity
por: Russo, Irene, et al.
Publicado: (2020)

Omalizumab for the Treatment of Chronic Spontaneous Urticaria: Association Between Body Mass Index and Outcome
por: Russo, Irene, et al.
Publicado: (2022)

Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease
por: Loganes, Claudia, et al.
Publicado: (2016)

Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis
por: Zaboli, Pardis, et al.
Publicado: (2017)

The Effect of Adiposity on Anti–Tumor Necrosis Factor-Alpha Levels and Loss of Response in Crohn's Disease Patients
por: Lim, Zixiang, et al.
Publicado: (2020)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
por: Fonseca, Ashley, et al.
Publicado: (2021)

Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
por: Eriksson, Carl, et al.
Publicado: (2023)

Extraintestinal manifestations of Crohn’s disease
por: Wójcik, Bartosz, et al.
Publicado: (2016)

High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
por: Elalouf, Ofir, et al.
Publicado: (2021)

Exosomes: Tiny Clues for Mast Cell Communication
por: D’Incà, Federica, et al.
Publicado: (2015)

Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion
por: Fujii, Takayuki, et al.
Publicado: (2017)

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma
por: Russo, Irene, et al.
Publicado: (2018)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_guc7nomgali5ckc6b75ae6jtda